medicare glp 1 coverage weight loss The GLP-1 Access Gap: Mapping Who Can Actually Afford America's Miracle Weight-Loss Drugs Nearly Four Million Medicare Beneficiaries
Description
Oral or injectable semaglutide for the management of type 2 diabetes in routine care: A multicentre observational study comparing matched cohorts
2024;44:NP809NP818
Direct vascular effects: GLP-1 receptors in blood vessels may mediate direct protective effects independent of metabolic improvements
Potential therapeutic effect of glucagon-like peptide-1 receptor agonists on COVID-19-induced pulmonary arterial hypertension
For persistent bloating
, & Lau, J
